In the latest squabble over the controversial 340B Drug Pricing Program, the AIDS Healthcare Foundation, which is an outspoken advocate for expanding services to patients, has filed a lawsuit accusing Johnson & Johnson for failing to offer required discounts on prescription medicines. After conducting an analysis, AHF claims that J&J was overpaid by more than $2 million between 2005 and 2013, but attempts to convince the health care giant to reclassify the specified drugs went nowhere. And AHF also maintains that J&J “deliberately, arbitrarily (and) oppressively” refusing to reclassify drugs for other organizations that are entitled to discounts but overpaid.
Help employers find you! Check out all the jobs and post your resume.
